RMHI Peak Pharmaceuticals, Inc.

Fundamentals / CIK 0001452804 / USD

Peak Pharmaceuticals, Inc. reported $102K in total assets and a net loss of $218K through September 30, 2022 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RMHI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2014 to 2022), reported in USD.

$1.54M$771K$0-$3.61MFY 2014 Net Income: -$3.76M2014FY 2015 Net Income: -$2.31M2015FY 2016 Net Income: $1.16M2016FY 2016 Net Income: $1.16M2016FY 2017 Net Income: -$51K2017FY 2018 Net Income: -$28K2018FY 2019 Net Income: -$14K2019FY 2020 Net Income: -$15K2020FY 2021 Net Income: -$76K2021FY 2022 Net Income: -$165K2022

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 1 Sep 30 Sep 30
Research & Development -- -- -- -- -- -- -- -- $13K $30K
Selling, General & Admin -- -- -- -- -- $24K $24K -- -- --
Total Operating Expenses $163K $69K $5.5K $5.7K $28K $45K -$1.09M -- $2.34M $3.09M
Operating Income -$163K -$69K -$5.5K -$5.7K -$28K -$45K $1.09M -- -$2.34M --
EBITDA -- -- -- -- -- -- $1.11M -- -$2.33M --
Interest Expense $32K $10K $9.5K $8.3K $5.6K $1.2K $0 -- $2.2K -$697K
Income Tax Expense -- -- -- -- -- -- $0 -- $0 --
Net Income -$165K -$76K -$15K -$14K -$28K -$51K $1.16M $1.16M -$2.31M -$3.76M
Basic EPS -- $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Diluted EPS -- $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Basic Shares Outstanding -- 78.4M 78.4M 78.4M 78.4M 78.4M 78.4M -- 78.3M 75.2M
Diluted Shares Outstanding -- 78.4M 78.4M 78.4M 78.4M 78.4M 80.9M -- 78.3M 75.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Total Operating Expenses $110K $53K $12K $47K $52K $3.7K $17K $43K
Operating Income -$110K -$53K -$12K -$47K -$52K -$3.7K -$17K -$43K
Interest Expense $1.8K $7.3K $8.0K $8.0K $8.8K $3.2K $2.4K $2.5K
Net Income -$112K -$60K $8.8K -$55K -$59K -$6.8K -$19K -$43K
Basic EPS -- -- -- $0.00 $0.00 -- $0.00 $0.00
Diluted EPS -- -- $0.00 $0.00 $0.00 -- $0.00 $0.00
Basic Shares Outstanding -- -- -- 78.4M 78.4M -- 78.4M 78.4M
Diluted Shares Outstanding -- -- 82.0M 78.4M 78.4M -- 78.4M 78.4M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $128K $261K $0 $0 $0 $0 $1.3K $202K $451K $4.9K
Cash & Short-Term Investments $128K $261K $0 $0 $0 $0 $1.3K $202K $451K $4.9K
Total Current Assets -- -- $408 $527 $2.3K $3.0K $1.3K $259K $458K $4.9K
Intangible Assets -- -- -- -- -- $35K $35K $17K -- --
Total Non-Current Assets -- -- $0 $0 $0 $0 $0 $22K $33K $0
Total Assets $130K $261K $408 $527 $2.3K $3.0K $1.3K $281K $491K $4.9K
Accounts Payable $225K $214K $163K $157K $153K $163K $83K $43K $44K --
Short-Term Debt -- -- -- -- -- -- -- -- $603K --
Total Current Liabilities -- -- $251K $236K $223K $196K $143K $289K $54K $44K
Total Non-Current Liabilities -- -- $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $622K $587K $251K $236K $223K $196K $143K $289K $54K $44K
Total Debt (incl. Leases) -- -- -- -- -- -- -- -- $603K --
Common Stock $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K $33K
Retained Earnings -$5.35M -$5.19M -$5.11M -$5.10M -$5.08M -$5.06M -$5.00M -$6.17M -$3.86M -$100K
Total Stockholders' Equity -$491K -$326K -$250K -$235K -$221K -$193K -$141K -$7.3K $436K -$39K
Total Equity -$491K -$326K -$250K -$235K -$221K -$193K -$141K -$7.3K $436K -$39K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Cash & Cash Equivalents $97K $128K $131K $176K $188K $261K $43K $348
Cash & Short-Term Investments $97K $128K $131K $176K $188K $261K $43K $348
Total Current Assets -- -- -- -- -- -- -- $348
Total Non-Current Assets -- -- -- -- -- -- -- $0
Total Assets $102K $130K $134K $180K $193K $261K $43K $348
Accounts Payable $307K $225K $175K $203K $197K $214K $225K $208K
Total Current Liabilities -- -- -- -- -- -- -- $301K
Total Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Liabilities $706K $622K $565K $620K $579K $587K $362K $301K
Common Stock $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K $7.8K
Retained Earnings -$5.47M -$5.35M -$5.29M -$5.30M -$5.25M -$5.19M -$5.18M -$5.16M
Total Stockholders' Equity -$603K -$491K -$431K -$440K -$386K -$326K -$319K -$300K
Total Equity -$603K -$491K -$431K -$440K -$386K -$326K -$319K -$300K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 1 Sep 30 Sep 30
Net Income -$165K -$76K -$15K -$14K -$28K -$51K $1.16M $1.16M -$2.31M -$3.76M
Depreciation & Amortization -- -- -- -- -- -- $19K -- $12K --
Stock-Based Compensation -- -- -- -- -- $0 -$1.30M -- $1.86M $1.22M
Change in Payables $21K $8.7K $4.6K $1.8K $4.4K $81K -- -- -- --
Operating Cash Flow -$69K -$14K -$119 -$1.7K -$44K -$18K -$200K -- -$248K -$933K
Capital Expenditure -- -- -- -- -- -- $0 -- -$2.2K --
Free Cash Flow -- -- -- -- -- -- -$200K -- -$250K --
Investing Cash Flow -- -- -- -- -- -- $0 -- -$2.2K -$35K
Financing Cash Flow -$65K $275K -- -- $43K $20K -- -- -- $1.42M
Net Change in Cash -$134K $261K -- -- -- -- -- -- -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Net Income -$112K -$60K $8.8K -$55K -$59K -$6.8K -$19K -$43K
Change in Payables $37K $66K -$36K -$2.7K -$6.2K -$15K $9.4K $12K
Operating Cash Flow -$31K -$3.7K -$9.7K -$11K -$44K -$14K -$60 -$30
Financing Cash Flow -- $0 -$35K $0 -$30K -- -- --
Net Change in Cash -$31K -$3.7K -- -- -$74K -- -- --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 1 Sep 30 Sep 30
Return on Equity (ROE) -- -- -- -- -- -- -- -- -- -861.2%
Return on Assets (ROA) -126.6% -29.1% -3679.2% -2655.2% -1251.4% -1712.7% 89128.5% 89128.5% -820.3% -765.7%
Current Ratio -- -- 0.00x 0.00x 0.01x 0.02x 0.01x 0.01x 0.90x 8.42x
Quick Ratio -- -- 0.00x 0.00x 0.00x 0.00x 0.01x 0.01x 0.70x 8.29x
Debt to Equity -- -- -- -- -- -- -- -- -- 1.38x
Operating Income Growth (YoY) -- -- -- -- -- -104.1% -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -104.4% -- -- -- --
5Y Net Income / Share Growth -- -106.5% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Return on Assets (ROA) -212.6% -126.6% -83.5% -77.7% -66.3% -29.1% -172.2% -16675.3%
Current Ratio -- -- -- -- -- -- -- 0.00x
Quick Ratio -- -- -- -- -- -- -- 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001452804) · from September 30, 2009 Data through December 31, 2022 · synced Nov 20, 2026, 05:50 UTC · Open in terminal